Company profile

NeuroWave

neurowavesystems.comHeadquarters: United States
11-50 employeesProduct Vendor
NeuroWave logo

Primary focus

Development and manufacture of non-invasive brain monitoring devices and research platforms for anesthesia, critical care, and defense applications.

Why it’s included

The company develops and manufactures the 'AutoTIVA System,' a portable closed-loop intravenous anesthesia system explicitly designed for automated anesthesia and analgesia delivery in deployable and resource-limited settings, directly addressing the topic's requirements for portability, automation, and safe anesthesia outside the operating room.

Relevant capabilities

  • Development of closed-loop anesthesia delivery platforms
  • Support for pharmacodynamic modeling and control-oriented validation
  • Deterministic wavelet-based cortical quantification (delay-free, per-second)
  • Real-time EEG signal processing and spectral metrics
  • High-resolution EEG acquisition hardware
Commercial sectorDepth-of-Anesthesia & Nociception Monitoring
Technology classesClosed-loop anesthesia control systems, Processed EEG depth-of-anesthesia monitors, Target-controlled infusion systems

Relevant commercial products

  • AutoTIVA System
  • AutoSED Module
  • Integrated closed-loop TIVA research prototype
  • Joint Multi-Channel Infusion Pump (JMCIP — MP-1500)
  • NeuroSENSE

Relevant patents

5 families, 5 publications
  • Intelligent pharmaceutical delivery system with automatic shutoff and method of using US-10130766-B1
  • Intelligent pharmaceutical delivery system with automatic shutoff and method of using US-12377215-B1
  • Anesthesia and/or sedation system and method US-11565042-B1
  • Systems and methods for controlled delivery of analgesic and hypnotic agents US-12377214-B2
  • Intelligent pharmaceutical delivery system with non-concentric pumping mechanism to reduce flow anomaly and method of using US-11986627-B1

← Back to what’s inside this report